Literature DB >> 16391472

Atrophic remodeling of the transplanted rat heart.

Saumya Sharma1, Jun Ying, Peter Razeghi, Stanislaw Stepkowski, Heinrich Taegtmeyer.   

Abstract

We have previously shown that the common feature of both pressure overload-induced hypertrophy and atrophy is a reactivation of the fetal gene program. Although gene expression profiles and signal transduction pathways in pressure overload hypertrophy have been well studied, little is known about the mechanisms underlying atrophic remodeling of the unloaded heart. Here, we induced atrophic remodeling by heterotopic transplantation of the rat heart. The activity parameters of three signal transduction pathways important in hypertrophy, i.e. mitogen-activated protein (MAP) kinase, mammalian target of rapamycin (mTOR), and Janus kinase/signal transducers and activators of transcription (JAK/STAT), were interrogated. Gene expression of upstream stimuli--insulin-like growth factor 1 (IGF-1) and fibroblast growth factor 2 (FGF-2)--and metabolic correlates, i.e. peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARalpha-regulated genes, of these pathways were also measured. In addition, we measured transcript levels of genes known to regulate skeletal muscle atrophy, all of which are negatively regulated by IGF-1 (Mafbx/Atrogin-1, MuRF-1). Atrophic remodeling of the heart was associated with increased expression of IGF-1 and FGF-2. Transcript levels of the nuclear receptor PPARalpha were decreased, as were the levels of PPARalpha-regulated genes. Furthermore, there was phosphorylation of ERK1, STAT3, and p70S6K with unloading. Consistent with the increase in IGF-1, we found a decrease in Mafbx/Atrogin-1 and MuRF-1 transcript levels. Rapamycin administration at 0.8 mg/kg/day for 7 days resulted in enhanced atrophy and attenuated the phosphorylation of ERK1, STAT3, and p70S6K without altering gene expression. We conclude that there is significant crosstalk between the mTOR, MAP kinase, and JAK/STAT signaling cascades. Furthermore, ubiquitin ligases, known to be essential for skeletal muscle atrophy, decrease in unloading-induced cardiac atrophy. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391472     DOI: 10.1159/000090550

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  17 in total

1.  Reverse remodelling and recovery from heart failure are associated with complex patterns of gene expression.

Authors:  Leanne Elizabeth Felkin; Enrique A Lara-Pezzi; Jennifer L Hall; Emma J Birks; Paul J R Barton
Journal:  J Cardiovasc Transl Res       Date:  2011-03-22       Impact factor: 4.132

2.  Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.

Authors:  Peter Razeghi; Mou-Er Wang; Keith A Youker; Leonard Golfman; Stanislaw Stepkowski; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2007-01-03       Impact factor: 10.787

Review 3.  Taking pressure off the heart: the ins and outs of atrophic remodelling.

Authors:  Kedryn K Baskin; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2011-02-25       Impact factor: 10.787

4.  Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.

Authors:  Soichiro Usui; Yasuhiro Maejima; Jayashree Pain; Chull Hong; Jaeyeaon Cho; Ji Yeon Park; Daniela Zablocki; Bin Tian; David J Glass; Junichi Sadoshima
Journal:  Circ Res       Date:  2011-05-26       Impact factor: 17.367

5.  Clenbuterol induces cardiac myocyte hypertrophy via paracrine signalling and fibroblast-derived IGF-1.

Authors:  Pankaj K Bhavsar; Nigel J Brand; Leanne E Felkin; Pradeep K Luther; Martin E Cullen; Magdi H Yacoub; Paul J R Barton
Journal:  J Cardiovasc Transl Res       Date:  2010-06-25       Impact factor: 4.132

Review 6.  Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies.

Authors:  Oliver Drews; Heinrich Taegtmeyer
Journal:  Antioxid Redox Signal       Date:  2014-10-01       Impact factor: 8.401

7.  P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.

Authors:  Wuqiang Zhu; Wenjun Zhang; Weinian Shou; Loren J Field
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

8.  MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

Authors:  Kedryn K Baskin; Meredith R Rodriguez; Seema Kansara; Wenhao Chen; Sylvia Carranza; O Howard Frazier; David J Glass; Heinrich Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2014-03-18       Impact factor: 5.000

Review 9.  Seek and destroy: the ubiquitin----proteasome system in cardiac disease.

Authors:  Jessica E Rodríguez; Jonathan C Schisler; Cam Patterson; Monte S Willis
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

10.  Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.

Authors:  Wuqiang Zhu; Mark H Soonpaa; Hanying Chen; Weihua Shen; R Mark Payne; Edward A Liechty; Randall L Caldwell; Weinian Shou; Loren J Field
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.